BusinessDutch watchdog fines Italian drug company for surcharge

Dutch watchdog fines Italian drug company for surcharge


The Hauge, Netherland: Italian pharmaceutical Leadiant has been fined almost 20 million euros for allegedly overcharging for medicine used to treat a rare cholesterol disease, the Dutch consumer watchdog said on Monday.

The Authority for Consumers and Markets “established that drug manufacturer Leadiant charged far too high a price for its prescription drug CDCA-Leadiant,” it said in a statement.

“As such, Leadiant abused its dominant position,” the Hague-based regulator said.

In just over a decade, the medicine’s name changed and its price leaped from 46 euros ($54) for a box of 100 capsules in 2008 to 14,000 euros in 2019, the ACM said.

This represented 153,000 euros per year for a patient, an amount the authority deemed “excessive” and “unfair”.

“After a small, low-risk investment, Leadiant implemented a huge price increase for a drug that had already existed for years,” ACM board chairman Martijn Snoep said.

“We consider this to be a very serious violation,” he said.

The ACM handed Leadiant a 19,569,500-euro fine.

The Italian pharmaceutical said it “fundamentally disagreed” with the fine, telling the Dutch ANP news agency it planned to challenge the decision.

“We are convinced that we have always acted correctly and in accordance with all applicable regulations,” Leadiant managing director Antonio Gama da Silva said.

The drug chenodeoxycholic acid (CDCA)-Leadiant is used for the treatment of patients with a rare hereditary metabolic disorder called cerebrotendinous xanthomatosis (CTX).

The rare condition affects the body’s ability to break down cholesterol fats and symptoms include brittle bones in children and dementia and seizures in adults.

In the Netherlands, approximately sixty patients suffer from this disease.

These individuals need to use the drug for the rest of their lives, the ACM said.

Leadiant maintained the price of 14,000 euros in the Netherlands until a hospital in Amsterdam managed to manufacture the same drug in its own laboratory in January 2020, the ACM noted.

AFP is a leading global news agency for comprehensive, verified coverage of events shaping the world.


Please enter your comment!
Please enter your name here

Latest news

Climate change could trigger internal migration of 216 mln people – World Bank

WASHINGTON, Sept 13 (Reuters) - Without immediate action to combat climate change, rising sea levels, water scarcity and declining...

Australia eyes Christmas reopening of international borders

SYDNEY — After more than 18 months of COVID-19 isolation, Australia is preparing to reopen its international borders by Christmas...

Vaccinated pregnant people can pass on Covid antibodies to fetus: Study

Pregnant women who are vaccinated against COVID-19 also pass on the coronavirus antibodies to their unborn children, according to...

End unilateral sanctions on Taliban, China urges G-20

ISLAMABAD — China’s top diplomat Thursday urged a virtual conference of G-20 foreign ministers to end economic sanctions against Taliban-ruled...

Supermodel Linda Evangelista says cosmetic treatment left her ‘deformed’

Kolkata, India: Linda Evangelista, one of the original 1990s supermodels who dominated the catwalk and fashion covers in the...

McD pledges to phase out plastic toys with Happy Meals by 2025

Fast-food giant McDonald's said Tuesday it would phase out plastic toys from its signature Happy Meals by 2025. "Starting now,...

Must read

You might also likeRELATED
Recommended to you